Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Quality Index
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow quality index. Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Quality Index of 7.00x as of September 2025. Operating cash flow of CN¥1.25 Billion exceeds net income of CN¥178.84 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Starlake Bioscience Co Inc Zhaoqing Guan to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Cash flow quality index of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. Historical Cash Flow Quality Index for Starlake Bioscience Co Inc Zhaoqing Guangdong across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 600866 equity to assets ratio to measure how much of total assets are equity-financed.
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Quality Index by Year (1998–2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full cash flow conversion analysis, see cash flow conversion of Starlake Bioscience Co Inc Zhaoqing Guan.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.32x | CN¥1.29 Billion | CN¥978.89 Million | ▼ -47.7% |
| 2024 | 2.52x | CN¥2.40 Billion | CN¥949.81 Million | ▼ -15.5% |
| 2023 | 2.99x | CN¥2.03 Billion | CN¥677.95 Million | ▲ +112.7% |
| 2022 | 1.41x | CN¥1.66 Billion | CN¥1.18 Billion | ▼ -22.3% |
| 2021 | 1.81x | CN¥192.63 Million | CN¥106.47 Million | ▲ +7.6% |
| 2020 | 1.68x | CN¥249.99 Million | CN¥148.71 Million | ▲ +17.9% |
| 2019 | 1.43x | CN¥213.17 Million | CN¥149.55 Million | ▲ +18.9% |
| 2018 | 1.20x | CN¥50.69 Million | CN¥42.28 Million | ▼ -29.2% |
| 2016 | 1.69x | CN¥41.17 Million | CN¥24.31 Million | ▲ +127.2% |
| 2013 | -6.23x | CN¥-28.16 Million | CN¥4.52 Million | ▼ -853.0% |
| 2011 | 0.83x | CN¥65.88 Million | CN¥79.63 Million | ▲ +123.5% |
| 2010 | 0.37x | CN¥104.63 Million | CN¥282.63 Million | ▼ -73.9% |
| 2009 | 1.42x | CN¥316.73 Million | CN¥223.68 Million | ▼ -73.2% |
| 2008 | 5.29x | CN¥148.93 Million | CN¥28.16 Million | ▲ +159.3% |
| 2006 | 2.04x | CN¥35.14 Million | CN¥17.23 Million | ▼ -43.5% |
| 2005 | 3.61x | CN¥46.83 Million | CN¥12.96 Million | ▲ +382.3% |
| 2004 | 0.75x | CN¥29.05 Million | CN¥38.79 Million | ▼ -64.3% |
| 2003 | 2.10x | CN¥149.70 Million | CN¥71.38 Million | ▼ -9.2% |
| 2002 | 2.31x | CN¥183.18 Million | CN¥79.30 Million | ▲ +158.8% |
| 2001 | 0.89x | CN¥60.82 Million | CN¥68.14 Million | ▼ -17.3% |
| 2000 | 1.08x | CN¥93.41 Million | CN¥86.50 Million | ▲ +43.9% |
| 1999 | 0.75x | CN¥52.97 Million | CN¥70.60 Million | ▼ -26.1% |
| 1998 | 1.01x | CN¥71.14 Million | CN¥70.09 Million | — |